ConductScience.org, home

Paper42921135PubMed

Tumor-associated macrophages in glioblastoma: implications for immunotherapy.

Lei J and 8 others. Front Immunol, 2026.

Cite this record

ConductScience Library. Tumor-associated macrophages in glioblastoma: implications for immunotherapy. Papers, record 42921135. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42921135

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor-associated macrophages in glioblastoma: implications for immunotherapy.
Journal
Front Immunol
Year
2026
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
Revised in PubMed
2026-10-27

Source PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lei JJianan
2Lao MMei
3Ni ZZhuona
4Chai WWenhao
5Fang MManrong
6Wen ZZhuzhen
7Lv XXuan
8Gao YYuxin
9Hu KKairui

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlioblastomaMajor topic
Tumor-Associated MacrophagesMajor topic
Brain NeoplasmsMajor topic
ImmunotherapyMajor topic
Humans
Tumor Microenvironment
Animals

Source PubMed

Download CSV of topics

References109

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138633388Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics.Comput Struct Biotechnol J2024https://conductscience.org/library/papers/38633388PubMed
240424600Polyamine acetylation mediates crosstalk between cancer cells and myeloid cells to promote mesenchymal/plurimetabolic states in glioblastoma.Neuro Oncol2025https://conductscience.org/library/papers/40424600PubMed
339928563The AURKA inhibitor alters the immune microenvironment and enhances targeting B7-H3 immunotherapy in glioblastoma.JCI Insight2025https://conductscience.org/library/papers/39928563PubMed
439631850Co-evolution of glioma and immune microenvironment.J Immunother Cancer2024https://conductscience.org/library/papers/39631850PubMed
539729678Addressing the role of surgery in brain tumour trials: A report from the neurosurgery committee of the EORTC brain tumour group.Eur J Cancer2025https://conductscience.org/library/papers/39729678PubMed
641783996Spatial transcriptomics characterisation of radionecrotic changes in glioblastoma patients.Neuro Oncol2026https://conductscience.org/library/papers/41783996PubMed
736841424CAR T-cells to treat brain tumors.Brain Res Bull2023https://conductscience.org/library/papers/36841424PubMed
839068459Decoding the spatiotemporal heterogeneity of tumor-associated macrophages.Mol Cancer2024https://conductscience.org/library/papers/39068459PubMed
940800581New Insights into Monocyte-Derived Macrophages in Glioblastoma.Research (Wash D C)2025https://conductscience.org/library/papers/40800581PubMed
1034145435Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics.Nat Rev Genet2021https://conductscience.org/library/papers/34145435PubMed
1142121941Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging Immunomodulators.Cells2026https://conductscience.org/library/papers/42121941PubMed
1240940872Choice of Animal Models to Investigate Cell Migration and Invasion in Glioblastoma.Cancers (Basel)2025https://conductscience.org/library/papers/40940872PubMed
1341992007Spatial and single-cell characterization of human glioblastoma tumor microenvironment reveals malignant cellular communities.Nat Neurosci2026https://conductscience.org/library/papers/41992007PubMed
1439626657V-domain immunoglobulin suppressor of T-cell activation and programmed death receptor 1 dual checkpoint blockade enhances antitumour immunity and survival in glioblastoma.Br J Pharmacol2025https://conductscience.org/library/papers/39626657PubMed
1537738997Primary brain tumours in adults.Lancet2023https://conductscience.org/library/papers/37738997PubMed
1639097091IRnet: Immunotherapy response prediction using pathway knowledge-informed graph neural network.J Adv Res2025https://conductscience.org/library/papers/39097091PubMed
1741903687Dual-targeting zein janus nanoparticles reprogram tumor-associated macrophages for enhanced glioblastoma therapy.Nanomedicine2026https://conductscience.org/library/papers/41903687PubMed
1841175739Small-molecule therapies targeting tumor-associated macrophages in glioma: mechanisms and potential.Int Immunopharmacol2026https://conductscience.org/library/papers/41175739PubMed
1941515934The Myeloid Biomarker MS4A6A Drives an Immunosuppressive Microenvironment in Glioblastoma via Activation of the PGE2 Signaling Axis.Int J Mol Sci2025https://conductscience.org/library/papers/41515934PubMed
2041414954The Immunosuppressive Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges and Future Directions.Immunology2026https://conductscience.org/library/papers/41414954PubMed

See all 109 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42921135

GET https://conductscience.org/api/papers/v1/42921135/references?page=2